Role of antiangiogenic agents in locally advanced and metastatic renal cancer in neoadjuvant situation: Report of 2 cases;Intérêt des anti-angiogéniques dans le cancer du rein localement avancé et métastatique en situation néo-adjuvante: à propos de 2 cas

Progres en Urologie

Volumn 18, Issue SUPPL.4, 2008, Pages

  Ferriere J M ^a   Wallerand, H ^a   Bernhard, J C ^a   Cornu, J N ^b   Roupret M ^b   Ravaud, A ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adjuvant therapy; Anti angiogenic; Renal cell cacrcinoma; Sunitinib; Tumor necrosis

Indexed keywords

ANGIOGENESIS INHIBITOR;

ADJUVANT THERAPY; ARTICLE; CANCER STAGING; CASE REPORT; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY;

ANGIOGENESIS INHIBITORS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING;

EID: 50849084883     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1166-7087(08)73668-6     Document Type: Article

References (15)

1. Ravaud A. New challenges in kidney cancer therapy: bevacizumab. Ann Oncol 18 Suppl 9 (2007) ix89
2. Mottet N. Place de la néphrectomie dans la prise en charge des cancers du rein métastatiques. Ann Urol 40 (2006) 273-279
3. Stein M.N., and Flaherty K.T. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma. Clin Cancer Res 13 (2007) 3765-3770
4. Dreicer R. Tyrosine kinase inhibitors compared with cytokine therapy for metastatic renal cell carcinoma: overview of recent clinical trials differentiating clinical response and adverse effects. Clin Genitourin Cancer 5 Suppl 1 (2006) S19-S23
5. Motzer R.J., Hutson T.E., Tomczak P., Michaelson M.D., Bukowski R.M., Rixe O., et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356 (2007) 115-124
6. Méjean A., Correas J.M., Escudier B., De Fromont M., Lang H., Long J.A., et al. Recommandations 2007 en onco-urologie : Tumeurs du rein. Prog Urol 17 (2007) 1101-1146
7. Karakiewicz P.I., Suardi N., Jeldres C., Audet P., Ghosn P., Patard J.J., et al. Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi. Eur Urol 53 (2007) 845-848 Epub 2007 Nov 20
8. Escudier B. Traitement du cancer du rein : les résultats cliniques du Nexavar. Prog Urol 17 (2007) 150-153
9. Escudier B., Eisen T., Stadler W.M., Szcylik C., Oudard S., Siebels M., et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356 (2007) 125-134
10. Trinh Q.D., Cardinal E., Gallina A., Perrotte P., Saad F., and Karakiewicz P.I. Sunitinib relieves renal cell carcinoma spinal cord compression. Eur Urol 51 (2007) 1741-1743
11. Motzer R.J., Michaelson M.D., Redman B.G., Hudes G.R., Wilding G., Figlin R.A., et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24 (2006) 16-24
12. Lebret T. Quelle place pour un traitement adjuvant après néphrectomie ?. Prog Urol 17 (2007) 148-149
13. Méjean A. La chirurgie du cancer du rein au stade localement avancé. Prog Urol 17 (2007) 136-138
14. Patard J.J. Les facteurs pronostiques dans le cancer du rein. Prog Urol 17 (2007) 139-143
15. Thiel D.D., and Winfield H.N. State-of-the-art surgical management of renal cell carcinoma. Expert Rev Anticancer Ther 7 (2007) 1285-1294